Pancreatitis Trial, Recruiting NCT06185621 Sponsor: Air Force Military Medical University, China Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT06185621
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had pancreatitis (painful inflammation of the pancreas) that has come back more than once

Who may not be able to join:

  • You have had fewer than 2 episodes of pancreatitis in the past year
  • Your pancreatitis was caused by a medical procedure (such as a scope procedure, surgery, or other invasive treatment) — these episodes do not count toward eligibility
  • You have had an allergic reaction to anti-inflammatory painkillers such as ibuprofen or naproxen (NSAIDs)
  • You regularly take aspirin or similar anti-inflammatory painkillers more than 3 times per week
  • You have an active stomach ulcer, or had a stomach ulcer or gastrointestinal bleeding within the last 3 months, significant liver or kidney disease, or certain abnormal blood clotting results (confirm with trial site)
  • You have gallstones
  • You have had, or are planning to have within the next 2 years, certain procedures such as gallbladder removal, pancreatic surgery, or specific scope-based treatments after your most recent episode of pancreatitis
  • You have very high triglyceride (fat) levels in your blood and are not receiving treatment to lower them
  • You have a condition called primary hyperparathyroidism that has been successfully treated after your last pancreatitis episode, or you are planning to have it treated within 2 years (confirm with trial site)
  • You drink heavily (more than about 4 standard drinks per day for men, or 3 for women) and have not stopped, or you experience significant symptoms when you try to stop drinking
  • You are currently pregnant or breastfeeding
  • You are unable to give your own consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613991811225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Air Force Military Medical University, China
Registry
ClinicalTrials.gov
Start date
1 November 2023
Est. completion
1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The mean interval between two consecutive occurrences of acute pancreatitis during follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov